Continuous glucose monitor from Medtronic wins EU approval

12/5/2012 | Star Tribune (Minneapolis-St. Paul, Minn.)

Medtronic has earned CE mark approval to market its Sentrino device in Europe. The technology, which is used to monitor a patient's glucose levels continuously and less invasively, is billed as the first such device designed for use in hospital critical care units.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR